Gaithersburg, Maryland, United States MedImmune Ventures is the famous VC, which was founded in 1987. The main department of described VC is located in the Gaithersburg. The fund was located in North America if to be more exact in United States. MedImmune Ventures seemed to be an CVC arrangement as part of the organization.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Health Care, Pharmaceutical. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight VLST Corporation, Iomai Corporation, Sequoia Pharmaceuticals. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the MedImmune Ventures, startups are often financed by Advanced Technology Ventures, Oxford Bioscience Partners, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are Advanced Technology Ventures, SV Health Investors, Oxford Bioscience Partners. In the next rounds fund is usually obtained by SV Health Investors, Pitango Venture Capital, Clarus Ventures.
Opposing the other organizations, this MedImmune Ventures works on 0 percentage points less the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2009. Speaking about the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations. The typical startup value when the investment from MedImmune Ventures is 5-10 millions dollars. The top amount of exits for fund were in 2015. The fund is constantly included in 2-6 deals per year.
Related Funds
| Fund Name | Location |
| 99 Tartans | Pennsylvania, Pittsburgh, United States |
| Alumni Capital Network | New York, New York, United States |
| Gresham House Renewable Energy VCT 1 | - |
| Ilmarinen Mutual Pension Insurance Company | Finland, Helsinki, Southern Finland |
| NetGain Energy Advisors | Alexandria, United States, Virginia |
| Sanluwu Zaixian Yiliao Keji | Beijing, China, Haidian |
| Skyline Global Partners | Chicago, Illinois, United States |
| Sophia Business Angels | France, Provence-Alpes-Cote d'Azur, Valbonne |
| Think IT | Beijing, China, Haidian |
| Tinder | California, United States, West Hollywood |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
G1 Therapeutics | $47M | 11 May 2016 | Durham, North Carolina, United States | ||
G1 Therapeutics | $33M | 05 Feb 2015 | Durham, North Carolina, United States | ||
VentiRx Pharmaceuticals | $50M | 23 Sep 2014 | Seattle, Washington, United States | ||
Catabasis Pharmaceuticals | $32M | 14 Nov 2013 | Cambridge, Massachusetts, United States | ||
G1 Therapeutics | $12M | 16 Oct 2013 | Durham, North Carolina, United States | ||
Applied Genetics Technologies Corporation | $37M | 19 Nov 2012 | Gainesville, Florida, United States | ||
Coferon | $12M | 16 Jul 2012 | New York, United States | ||
Catabasis Pharmaceuticals | $8M | 13 Dec 2011 | Cambridge, Massachusetts, United States | ||
Catabasis Pharmaceuticals | $14M | 08 Dec 2010 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
G1 Therapeutics | $47M | 11 May 2016 | Durham, North Carolina, United States | ||
G1 Therapeutics | $33M | 05 Feb 2015 | Durham, North Carolina, United States | ||
VentiRx Pharmaceuticals | $50M | 23 Sep 2014 | Seattle, Washington, United States | ||
Catabasis Pharmaceuticals | $32M | 14 Nov 2013 | Cambridge, Massachusetts, United States | ||
G1 Therapeutics | $12M | 16 Oct 2013 | Durham, North Carolina, United States | ||
Applied Genetics Technologies Corporation | $37M | 19 Nov 2012 | Gainesville, Florida, United States | ||
Coferon | $12M | 16 Jul 2012 | New York, United States | ||
Catabasis Pharmaceuticals | $8M | 13 Dec 2011 | Cambridge, Massachusetts, United States | ||
Catabasis Pharmaceuticals | $14M | 08 Dec 2010 | Cambridge, Massachusetts, United States |
